Invention Grant
- Patent Title: Oligomers and oligomer conjugates
-
Application No.: US17013374Application Date: 2020-09-04
-
Publication No.: US11591598B2Publication Date: 2023-02-28
- Inventor: Hassan Javanbakh , Søren Ottosen , Morten Lindow
- Applicant: Hoffmann-La Roche Inc.
- Applicant Address: US NJ Little Falls
- Assignee: Hoffmann-La Roche Inc.
- Current Assignee: Hoffmann-La Roche Inc.
- Current Assignee Address: US NJ Little Falls
- Agency: Fish & Richardson P.C.
- Priority: GB1408623 20140515
- Main IPC: C12N15/113
- IPC: C12N15/113 ; A61K31/712 ; A61K31/713 ; A61K47/54 ; A61K48/00
Abstract:
The present invention relates to an oligomer conjugate for use in the treatment of a viral disorder. The oligomer conjugate comprises: a) an oligomer capable of modulating a target sequence in HBx and/or HBsAg of Hepatitis B Virus (HBV) to treat said viral disorder; and b) a carrier component capable of delivering the oligomer to the liver which is linked, preferably conjugated, to the oligomer.
Public/Granted literature
- US20210054381A1 OLIGOMERS AND OLIGOMER CONJUGATES Public/Granted day:2021-02-25
Information query
IPC分类:
